Skip to main content
. 2013 Sep 16;32(1):66. doi: 10.1186/1756-9966-32-66

Table 2.

Relationship of EPCAM expression with pathological parameters of tumor

Clinical parameters
EPCAM
  Low High t/χ2/r P
Age(yrs)
56.85 ± 11.4
61.51 ± 12.22
4.787
0.0001
Gender
 
 
0.805
0.370
Male
257 (60.0%)
171 (40.0%)
 
 
Female
97 (56.1%)
76 (43.9%)
 
 
Location
 
 
10.37
0.006
Proximal
37 (44.0%)
47 (56.0%)
 
 
Middle
130 (58.3%)
93 (41.7%)
 
 
Distal
187 (63.6%)
107 (36.4%)
 
 
Size
 
 
40.47
0.0001
<5 cm
244 (69.7%)
106 (30.3%)
 
 
≥5 cm
110 (43.8%)
141 (56.2%)
 
 
Lauren classification
 
 
198.1
0.0001
Intestinal
261 (87.3%)
38 (12.7%)
 
 
Diffuse
93 (30.8%)
209 (69.2%)
 
 
Histology
 
 
3.136
0.371
Papillary adenocarcinoma
20 (69.0%)
9 (31.0%)
 
 
Tubular adenocarcinoma
254 (57.9%)
185 (42.1%)
 
 
Mucinous adenocarcinoma
19 (51.4%)
18 (48.6%)
 
 
Signet-ring cell carcinoma
61 (63.5%)
35 (36.5%)
 
 
Histologic differentiation
 
 
6.323
0.097
Well
12 (70.6%)
5 (29.4%)
 
 
Moderately
113 (64.6%)
62 (35.4%)
 
 
Poorly
227 (55.8%)
180 (44.2%)
 
 
Others
2 (100.0%)
0 (0.0%)
 
 
Invasion depth
 
 
107.1
0.0001
T1
73 (91.2%)
7 (8.8%)
 
 
T2
113 (80.1%)
28 (19.9%)
 
 
T3
160 (47.3%)
178 (52.7%)
 
 
T4
8 (19.0%)
34 (81.0%)
 
 
TNM stages
 
 
201.6
0.0001
I
119 (93.7%)
8 (6.3%)
 
 
II
116 (85.9%)
19 (14.1%)
 
 
III
99 (42.9%)
132 (57.1%)
 
 
IV
20 (18.5%)
88 (81.5%)
 
 
Lymphatic metastasis
 
 
119.1
0.0001
No
193 (87.7%)
27 (12.3%)
 
 
Yes
161 (42.3%)
220 (57.5%)
 
 
Regional lymph nodes
 
 
182.6
0.0001
PN0
193 (87.7%)
27 (12.3%)
 
 
PN1
118 (59.6%)
80 (40.4%)
 
 
PN2
42 (31.1%)
93 (68.9%)
 
 
PN3
1 (2.1%)
47 (97.9%)
 
 
Distant metastasis
 
 
53.42
0.0001
No
332 (65.1%)
178 (34.9%)
 
 
Yes 22 (24.2%) 69 (75.8%)